Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortality.

Dickerson F, Boronow J, Stallings C, Origoni A, Yolken R.

Schizophr Bull. 2007 May;33(3):737-40. Epub 2007 Feb 20.

2.

Early infections of Toxoplasma gondii and the later development of schizophrenia.

Mortensen PB, Nørgaard-Pedersen B, Waltoft BL, Sørensen TL, Hougaard D, Yolken RH.

Schizophr Bull. 2007 May;33(3):741-4. Epub 2007 Feb 28.

3.

A controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence.

Hinze-Selch D, Däubener W, Eggert L, Erdag S, Stoltenberg R, Wilms S.

Schizophr Bull. 2007 May;33(3):782-8. Epub 2007 Mar 26. Erratum in: Schizophr Bull. 2011 May;37(3):652.

4.

Toxoplasma gondii infection and schizophrenia: a case control study in a low Toxoplasma seroprevalence Mexican population.

Alvarado-Esquivel C, Urbina-Álvarez JD, Estrada-Martínez S, Torres-Castorena A, Molotla-de-León G, Liesenfeld O, Dubey JP.

Parasitol Int. 2011 Jun;60(2):151-5. doi: 10.1016/j.parint.2010.12.003. Epub 2011 Feb 1.

PMID:
21292026
5.

Anti-Toxoplasma gondii antibodies in patients with schizophrenia--preliminary findings in a Turkish sample.

Cetinkaya Z, Yazar S, Gecici O, Namli MN.

Schizophr Bull. 2007 May;33(3):789-91. Epub 2007 Apr 2.

6.
7.

Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth.

Mortensen PB, Nørgaard-Pedersen B, Waltoft BL, Sørensen TL, Hougaard D, Torrey EF, Yolken RH.

Biol Psychiatry. 2007 Mar 1;61(5):688-93. Epub 2006 Aug 22.

PMID:
16920078
8.

Antibodies to infectious agents in individuals with recent onset schizophrenia.

Leweke FM, Gerth CW, Koethe D, Klosterkötter J, Ruslanova I, Krivogorsky B, Torrey EF, Yolken RH.

Eur Arch Psychiatry Clin Neurosci. 2004 Feb;254(1):4-8.

PMID:
14991372
9.

Effects of toxoplasma on human behavior.

Flegr J.

Schizophr Bull. 2007 May;33(3):757-60. Epub 2007 Jan 11.

10.

Seroepidemiology of infection with Toxoplasma gondii in waste pickers and waste workers in Durango, Mexico.

Alvarado-Esquivel C, Liesenfeld O, Márquez-Conde JA, Cisneros-Camacho A, Estrada-Martínez S, Martínez-García SA, González-Herrera A, García-Corral N.

Zoonoses Public Health. 2008 Aug;55(6):306-12. doi: 10.1111/j.1863-2378.2008.01133.x. Epub 2008 May 16.

PMID:
18489540
11.

Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia.

Yolken RH, Bachmann S, Ruslanova I, Lillehoj E, Ford G, Torrey EF, Schroeder J.

Clin Infect Dis. 2001 Mar 1;32(5):842-4. Epub 2001 Feb 28. Erratum in: Clin Infect Dis 2001 Apr 15;32(8):1247. Rouslanova I [corrected to Ruslanova I].

PMID:
11229859
13.

Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.

Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.

Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89.

PMID:
19554969
14.

Antibodies to infectious agents in individuals at ultra-high risk for psychosis.

Amminger GP, McGorry PD, Berger GE, Wade D, Yung AR, Phillips LJ, Harrigan SM, Francey SM, Yolken RH.

Biol Psychiatry. 2007 May 15;61(10):1215-7. Epub 2007 Jan 3.

PMID:
17207471
15.

Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis.

Torrey EF, Bartko JJ, Lun ZR, Yolken RH.

Schizophr Bull. 2007 May;33(3):729-36. Epub 2006 Nov 3.

16.

Risk factors for Toxoplasma gondii infection in the United States.

Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG.

Clin Infect Dis. 2009 Sep 15;49(6):878-84. doi: 10.1086/605433.

PMID:
19663709
17.

Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality.

Arora S, Jenum PA, Aukrust P, Rollag H, Andreassen AK, Simonsen S, Gude E, Fiane AE, Geiran O, Gullestad L.

J Am Coll Cardiol. 2007 Nov 13;50(20):1967-72. Epub 2007 Oct 29.

18.

Seroprevalence of and risk factors for Toxoplasma gondii antibodies among asymptomatic blood donors in Egypt.

Elsheikha HM, Azab MS, Abousamra NK, Rahbar MH, Elghannam DM, Raafat D.

Parasitol Res. 2009 Jun;104(6):1471-6. doi: 10.1007/s00436-009-1350-z. Epub 2009 Feb 6.

PMID:
19198880
19.

Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia.

Okusaga O, Langenberg P, Sleemi A, Vaswani D, Giegling I, Hartmann AM, Konte B, Friedl M, Groer MW, Yolken RH, Rujescu D, Postolache TT.

Schizophr Res. 2011 Dec;133(1-3):150-5. doi: 10.1016/j.schres.2011.08.006. Epub 2011 Sep 3.

PMID:
21890329
20.

Toxoplasma and schizophrenia.

Yolken RH, Dickerson FB, Fuller Torrey E.

Parasite Immunol. 2009 Nov;31(11):706-15. doi: 10.1111/j.1365-3024.2009.01131.x. Review.

Supplemental Content

Support Center